Hypersensitivity to Cetuximab After Geographic Relocation

Am J Ther. 2018 Nov/Dec;25(6):e699-e700. doi: 10.1097/MJT.0000000000000709.

Authors

Allison A Baxley¹, Oyinkansola A Doyin-Lipede², Mohammad A Razaq³

Affiliations

¹ Department of Clinical Pharmacy Services, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
² Department of Pharmacy Practice, University of Oklahoma College of Pharmacy, Oklahoma City, OK.
³ Section of Hematology-Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK.

PMID: 29309281
DOI: 10.1097/MJT.0000000000000709

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
California
Cetuximab / adverse effects*
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / etiology*
Head and Neck Neoplasms / drug therapy*
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Oklahoma
Travel-Related Illness*

Substances

Antineoplastic Agents, Immunological
Cetuximab